ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

182 hedge funds and large institutions have $1.41B invested in Array Biopharma Inc in 2017 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 70 increasing their positions, 61 reducing their positions, and 28 closing their positions.

Holders
182
Holders Change
-5
Holders Change %
-2.67%
% of All Funds
4.54%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
24
Increased
70
Reduced
61
Closed
28
Calls
$24.3M
Puts
$24.2M
Net Calls
+$63K
Net Calls Change
-$2.68M
Name Market Value Shares Shares
Change
Shares
Change %
FRM
201
Fox Run Management
Connecticut
-12,700 Closed
CCT
202
Country Club Trust
Missouri
-10,375 Closed
FMT
203
First Mercantile Trust
Tennessee
-8,930 Closed
CAG
204
Crestwood Advisors Group
Massachusetts
-5,000 Closed
SCM
205
Segantii Capital Management
Hong Kong
-1,000 Closed
FMA
206
FNY Managed Accounts
New York
-750 Closed
TRCT
207
Tower Research Capital (TRC)
New York
-639 Closed
CPIG
208
Chicago Partners Investment Group
Illinois
-550 Closed
HMS
209
Hanseatic Management Services
New Mexico
-142 Closed
PA
210
Parallel Advisors
California
-94 Closed
ES
211
Equitec Specialists
Illinois
NC
212
Nexthera Capital
New York
CLCM
213
Crawford Lake Capital Management
New Jersey
JPMorgan Chase & Co
214
JPMorgan Chase & Co
New York
CL
215
CSS LLC
Illinois
EWM
216
Edge Wealth Management
New York
TI
217
Telemetry Investments
New York
Parallax Volatility Advisers
218
Parallax Volatility Advisers
California
ID
219
Integral Derivatives
New York
WAM
220
Wolverine Asset Management
Illinois
ACP
221
Acuta Capital Partners
California